Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.33 |
| ▸ | PTP4A2 | Q12974 | 1/20 | 0.33 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.33 |
| ▸ | TYMP | P19971 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20240244 | 0.88 | ALOX5 (0.34) | EGFRALOX5 | |
| SCHEMBL10054157 | 0.80 | CYP2A6 (0.39) | MAPTKDM4EALDH1A1ALOX5ESR1 | |
| SCHEMBL232342 | 0.80 | ALDH1A1 (0.39) | MAPTMAPK1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL20248867 | 0.78 | PTP4A3 (0.49) | MAPTKDM4EALDH1A1LMNAPTP4A3 | |
| SCHEMBL14964002 | 0.75 | CHEK1 (0.38) | MAPTMAPK1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL10028812 | 0.73 | GPR3 (0.36) | EGFRMAPTALDH1A1RAB9A | |
| SCHEMBL19267451 | 0.72 | PTP4A3 (0.38) | MAPTKDM4EALDH1A1LMNAPTP4A3 | |
| SCHEMBL10054142 | 0.72 | DHFR (0.37) | MAPK1L3MBTL1KDM4EALDH1A1TYMP | |
| SCHEMBL14603456 | 0.71 | EGFR (0.35) | EGFRMAPT | |
| SCHEMBL30507470 | 0.71 | EGFR (0.35) | EGFRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10347846-B2 | Organic compound for organic EL device and using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-07-09 | — | — | US | disclosed |
| US-20180166640-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-06-14 | — | — | US | disclosed |
| US-20180166640-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-06-14 | — | — | US | disclosed |
| US-9394406-B2 | Polymers containing substituted benzodithiophene units, blends comprising these polymers, and devices comprising these polymers or blends | MERCK PATENT GMBH (DE) | 2016-07-19 | — | — | US | disclosed |
| US-9394406-B2 | Polymers containing substituted benzodithiophene units, blends comprising these polymers, and devices comprising these polymers or blends | MERCK PATENT GMBH (DE) | 2016-07-19 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| EP-2850668-A2 | HOLE TRANSPORT MATERIALS INCLUDING OLED APPLICATIONS | Solvay USA Inc. (US) | 2015-03-25 | — | — | EP | disclosed |
| WO-2013173396-A2 | HOLE TRANSPORT MATERIALS INCLUDING OLED APPLICATIONS | PLEXTRONICS, INC. (US) | 2013-11-21 | — | — | WO | disclosed |
| US-20130126855-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2013-05-23 | — | — | US | disclosed |
| US-20130126855-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2013-05-23 | — | — | US | disclosed |
| WO-2012013310-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS CONTAINING SAID POLYMERS, AND DEVICES CONTAINING SAID POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2012-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10347846-B2 | Organic compound for organic EL device and using the same | L1CAM, ESR1, XPO4 | EGFR 1934/4885MAPT 1852/4885MAPK1 2517/4885 |
| US-20180166640-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | L1CAM, ESR1, XPO4 | EGFR 1934/4885MAPT 1852/4885MAPK1 2517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.